Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. - Wikidata - wikimedia - TriplyDB

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

http://www.wikidata.org/entity/Q37589185

about

Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice Pentavalent antimonials: new perspectives for old drugs Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconate Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors Preparation and properties of liposome-associated gentamicin.Clinical and experimental advances in treatment of visceral leishmaniasis.Delivery strategies for antiparasitics.Incorporation of recombinant gamma interferon into liposomes enhances its ability to induce peritoneal macrophage antitoxoplasma activity.In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis.In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomes Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages Current treatment recommendations for leishmaniasis.Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys Treatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B.Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study.Development of new derivatives of primaquine by association with lysosomotropic carriers.Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels.Bioengineered nanoparticles for siRNA delivery.Drug delivery strategies for therapy of visceral leishmaniasis.Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis New delivery strategies for the old pentavalent antimonial drugs.Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives.Targeting macrophage subsets for infarct repair.Nanomedicines in gastroenterology and hepatology.Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.Non-viral nucleic acid containing nanoparticles as cancer therapeutics Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity.Preparation and use of liposomes in the treatment of microbial infections.Targeting of liposomes to tumor cells in vivo.Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog.Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes.Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.The chemotherapy of protozoal infections: whither?Liposomes in the treatment of infections.

P2860

Q24657256-FE3C62BB-0F42-4598-B64F-757E2D45D5D1 Q26744835-73B710CE-D1C6-4085-A94A-F3712E2E8F08 Q27478096-A1838CB5-E0B9-4F63-B586-CA5D7C45645A Q28253055-B497FC9E-05A3-4EE5-994D-5FBA61298804 Q28343232-C76E96E6-89F6-4B45-ACAB-3B4D84028085 Q28361166-AC81954E-C820-49B9-9F1E-10AF3A97127E Q28477398-88F4B321-5734-4E8C-AFCE-56B7A2F95CF4 Q33649082-70863A87-1BE8-4796-9F68-59D58F6A8D1D Q33726411-0A6DA265-4BF1-4D85-B65E-6518C44EC147 Q33982648-5D5ABB8D-5251-4914-AB57-D5DFB6580255 Q35056056-F0716702-E147-45CA-A5D2-73251B2B38D9 Q35088834-91BC091D-BDA1-44C1-B8B4-507AEB3EB90B Q35270608-6D680A01-0775-4EDA-9635-4659162D80FA Q35311986-9A77C913-838A-4016-A3E4-1D3A25680162 Q35651604-956A6A68-5111-4A67-986F-65C48F5AEB53 Q35653378-022C42E6-2E9A-45B4-9B40-A6566125ECCE Q35653579-5569CCEE-8B16-40B2-83A5-77A6CE7F76A7 Q35760259-2E291D68-A7AC-4D7A-9166-C5C6B16E4355 Q36397370-410C5280-7DF3-4DC5-BB0F-F7152B74BC9C Q36675517-6337A8CE-9236-4676-AA2F-750CAF94D1EF Q37307526-BF7A9286-CC41-4B65-819B-2019846BD59E Q37679156-A0848E03-E463-44B7-A3CB-09C847E03943 Q37702257-0E79D4F0-7439-4DE7-9779-2155F5EF2CE1 Q37722715-2E19C512-42D2-4E60-B3CC-12152D80B910 Q37804399-CF63513F-8B7D-4FC4-B164-86A40A6431DC Q37845396-4751925C-A47C-4F91-AC80-85EC80AC137D Q38154347-30ABA6F0-61CD-42F9-89BE-702AA7C6877D Q38221014-44E6BAF7-23F2-42D8-AA5E-AC5B558AA538 Q38370747-8801E16F-DEC2-440F-9950-3099F4CA56B0 Q38689437-8982D4AC-C507-4B07-9148-3044747190B0 Q38849963-FE54BA5B-CAE9-492E-9EDC-3EB4F0E69D4A Q38856246-3F704106-DF3B-4C35-AB98-A8F1F71C9C6C Q38914848-36BBE12D-308E-4955-A2B0-E3BAE6560B4A Q39654122-54C44BCF-4EC8-468C-827C-85A22146E2F9 Q39696588-CAB954CD-6ADE-4092-8850-AA2F42E7878F Q39815819-1352C0CA-5610-4832-B136-537CC03E14D1 Q39834052-B74B7C1B-9E61-41AF-B6FC-1BCD5C4011AB Q39955167-B36D42CC-D7D7-489E-B0C8-43A5E0F25D99 Q40125390-A0514912-E675-40C9-AFA6-813D9A80BDB8 Q40499095-57020D6E-69FC-49E5-AF30-A1052FDB3570

P2860

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

http://www.wikidata.org/entity/Q37589185

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 1978

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

@en

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

@nl

type

label

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

@en

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

@nl

prefLabel

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

@en

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

@nl

P1433

Q37589185-C723A25D-3ED6-46D3-B3CB-A6D87442E393

P1476

Q37589185-59A48F68-0665-46C4-A25E-AE80F04DACAC

P2093

Q37589185-0568D550-7515-42C7-8E40-98AC387C5C58

Q37589185-2BEEE098-0AEC-4C92-94C4-D56B906A5DAC

Q37589185-35D39ACE-9B48-48D6-AB2C-F70C03FD6432

Q37589185-3731D3CE-9FE6-4E8F-8281-6A8290790216

Q37589185-607B3922-C2F5-469A-A0BC-E16A679485BB

Q37589185-A374D214-3B5A-4CF9-B7C4-5E795F229A94

Q37589185-FF7DD319-C2DF-44C5-BFA2-76FA612B41DA

P2860

Q37589185-0044F555-A15A-46CA-90CC-4A54CE77FA28

Q37589185-03101A6E-7BAB-427F-90D6-8A9C0A856AE0

Q37589185-0A684EAE-76CD-4C11-9E00-DA4C351C660A

Q37589185-16284D82-D8F9-473F-AB3C-36942B20BD39

Q37589185-24E26C8C-A9CA-4659-B298-2BEAA5ECA9D1

Q37589185-33AC3396-0E08-4C12-B33E-9E628D403555

Q37589185-656257AF-181A-4E77-9AA7-4521C6C0FD21

Q37589185-66815F61-317F-4659-8441-4C5CA349D673

Q37589185-829716A2-197D-43D9-9DE1-0A4D253DB05E

Q37589185-8C1E0508-2B13-451B-AA4C-59DC7D38C2D8

P304

Q37589185-4F28A185-A58C-445D-B8D6-21D9D1EA1917

P31

Q37589185-E58BBDF2-0C48-408A-9ACE-95EEBC78B8FB

P356

Q37589185-C8D6653D-8517-49C4-BDD1-FD279CDD5885

P407

Q37589185-287E6CCF-C2ED-4D2E-A937-08322597B1AE

P433

Q37589185-9677AA5D-A9E2-4F44-B0ED-7B05F4B1C713

P478

Q37589185-1124B1E9-11B0-4F38-8F75-1BE55D89B0AE

P577

Q37589185-3CABFB82-F86F-4B51-8AA1-C2FE653FCD10

P5875

Q37589185-1FBE984A-EAD8-414C-A550-CF300C805773

P698

Q37589185-81BB0A88-CA6E-4E81-BABE-63AAE42479F0

P932

Q37589185-45C359D7-DCFA-4EAD-BF6F-E08884241C61

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

@en

P2093

Alving CR

http://www.w3.org/2001/XMLSchema#string

Chapman WL Jr

http://www.w3.org/2001/XMLSchema#string

Hanson WL

http://www.w3.org/2001/XMLSchema#string

Hendricks LD

http://www.w3.org/2001/XMLSchema#string

Steck EA

http://www.w3.org/2001/XMLSchema#string

Swartz GM Jr

http://www.w3.org/2001/XMLSchema#string

Waits VB

http://www.w3.org/2001/XMLSchema#string

P2860

Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal.

Membrane models with phospholipids.

A morphologic and biochemical study of the fate of antibody-bearing liposomes.

Morphological observations on the cellular and subcellular destination of intravenously administered liposomes.

Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases.

Antileishmanial activity of antimonials entrapped in liposomes.

The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.

The carrier potential of liposomes in biology and medicine (second of two parts).

New aspects of liposomes.

Liposomes as drug carriers.

P304

2959-2963

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.75.6.2959

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

1978-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

22929179

http://www.w3.org/2001/XMLSchema#string

P698

208079

http://www.w3.org/2001/XMLSchema#string

P932

392686

http://www.w3.org/2001/XMLSchema#string